World-Renowned Cancer Researcher Dr. A. Thomas Look Announced as Keynote Speaker for InnoPharm-2026
By: Gayatri Srinivas
Conference Manager, InnoPharm-2026
09/06/2026
InnoPharm-2026, the Second International Conference on Innovations in Pharma R&D, is pleased to announce that Dr. A. Thomas Look, Professor at Dana-Farber Cancer Institute and Harvard Medical School, will join the conference as a Keynote Speaker.
Dr. Look is internationally recognized for his pioneering contributions to cancer genetics and pediatric oncology. Throughout his distinguished career, he has led groundbreaking research that identified critical genetic alterations driving leukemia and other childhood cancers.
His discoveries have significantly advanced the understanding of cancer biology and contributed to the development of targeted therapies that have improved patient outcomes worldwide.
As one of the leading figures in translational cancer research, Dr. Look has dedicated decades to bridging laboratory discoveries with clinical applications. His expertise spans cancer genomics, molecular oncology, and the identification of novel therapeutic targets, helping shape the future of precision medicine and innovative cancer treatments.
"We are honored to welcome Dr. A. Thomas Look to InnoPharm-2026," said Gayatri Srinivas, Conference Manager. "His groundbreaking work has transformed the field of oncology and continues to inspire researchers, clinicians, and industry leaders worldwide."
InnoPharm-2026 will bring together pharmaceutical scientists, biotechnology innovators, academic researchers, healthcare professionals, and industry leaders from around the globe to discuss the latest advances in drug discovery, development, clinical research, artificial intelligence in healthcare, precision medicine, and pharmaceutical innovation.
The conference will take place on November 2–4, 2026, in Boston, Massachusetts, providing a premier platform for scientific exchange, collaboration, and networking among leaders in the life sciences sector.
For more information about InnoPharm-2026, speaker opportunities, sponsorships, and registration, please visit the conference website.
About Dr. A. Thomas Look
- Professor, Dana-Farber Cancer Institute and Harvard Medical School
- International leader in cancer genetics and pediatric oncology
- Pioneer in identifying genetic drivers of leukemia and childhood cancers
- Contributor to targeted cancer therapies and precision medicine
- Expert in cancer genomics and translational oncology research
About InnoPharm-2026
InnoPharm-2026 (Second International Conference on Innovations in Pharma R&D) is an international gathering of researchers, scientists, clinicians, and industry professionals focused on advancing pharmaceutical research and development.
The conference showcases cutting-edge discoveries, emerging technologies, and collaborative opportunities that are shaping the future of healthcare and medicine.